Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban vs Lepirudin in Critically Ill Patients with HIT (ALiCia)
NCT00798525Phase 4Terminated
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Jan 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of argatroban in heparin-induced thrombocytopenia (HIT), sponsored by Heinrich Heine University Düsseldorf. Started Jan 2009; status: terminated.
02
Drugs
argatroban
03
Conditions
heparin-induced thrombocytopenia (HIT)
Beyond the preview
Go deeper on NCT00798525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798525.